BUN Testing Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

The global BUN testing market was valued at USD 2.1 billion in 2022, and a CAGR of 5.6% is expected during the forecast period. An increasing number of chronic kidney disease patients is driving significant growth in the market. Increasing disposable income and improvements in health infrastructure are another key factor driving growth in the market. Rising healthcare expenditure and increasing health awareness among the people are driving growth in the market significantly.

Early detection and monitoring are critical, especially as kidney disorders often go undiagnosed until the advanced stage. The aging population is more susceptible to kidney-related ailments. Increasingly, geriatric people are more susceptible to these diseases due to the increasing chance of diabetes and hypertension, which cause kidney diseases. Rapidly growing world population and increasing initiatives by government in all parts of the world are driving growth in the market significantly.

Growth Drivers

Public awareness about kidney health and the importance of regular screening has grown, especially as these tests detect issues in the early stages. Innovations in diagnostic equipment are making BUN tests faster and more accurate. Automated analyzers and portable devices have simplified testing procedures, making them available in remote areas and for home monitoring. Conditions like hypertension, diabetes, and obesity are known to impact kidney health. Since BUN level indicates kidney function in patients with lifestyle-related conditions, Increased healthcare spending and government initiatives targeting kidney disease management and awareness are indirectly driving the demand for BUN testing.

The increasing number of pathologies and technological advancement in the market is significantly driving growth in the market. The increasing prevalence of chronic diseases is driving significant growth in the market. Rising worldwide government initiatives are the major key factor behind the significant growth in the market. The convenience of performing renal function tests at home is a big factor behind the significant growth in the market. Recent years, especially post-pandemic, have been an era of increasing health awareness among people in the world significantly. Medical camps are organized by the government and NGOs in many countries.

The increasing number of diabetic and obese people due to hectic life- schedules are the key factors driving growth in the market significantly.

Segmentation

By Type

·         Elisa

·         Colorimetric

·         Spectrophotometric

By End-User

·         Hospitals

·         Laboratories

·         Clinics

·         Others

Regional Outlook

·         Asia Pacific

·         Europe

·         North America

·         Latin America

·         Middle East and Africa

Global BUN Testing Market by End-User Segmentation

On the basis of the end-user, the global BUN testing market is segmented into hospitals, laboratories, clinics, and others. Hospitals are the leading segment due to the greatest number of patient flow in the hospitals during a normal day. Increasing health awareness among the people is the key factor behind the significant growth in the market. There are some lucrative offers on Full body testing in hospitals most of the time is the key reason behind the significant growth in the market.

Emerging economies like China, India, and South Korea, along with Japan, are witnessing significant growth in the market due to rising disposable income, and increasing urbanization is driving growth in the market significantly. Governments all over the region are taking initiatives to raise awareness about chronic kidney diseases, which is a significant factor behind the growth in the market.

Path labs and diagnostic centers are another leading segment in the market due to their efficient working methodology, and increasing customer flow is motivating these pathologies and laboratories to work efficiently and significantly contribute to growing market share. Ongoing research and development and the number of increasing patients has inspired the skilled students to build their careers in medicine, and so the clinics segment is also witnessing growth during the forecast period. Digital urology at home to contribute significantly to kidney assessment tests.

Regional Outlook 

On the basis of the regions, the global BUN testing market is segmented into 5 regions: Asia Pacific, North America, Latin America, the Middle East and Africa, and Europe. The increasing number of chronic kidney disease patients in the region due to the growing geriatric population and having the best healthcare infrastructure is the reason behind the sheer dominance in the North American region. The data published by the Centers for Disease Control and Prevention show that 37 million adults in the North American region are suffering from chronic kidney diseases, which is boosting the market growth significantly.

Government expenditure in the healthcare sector is significant and growing the market significantly. Advancements in renal function testing technology have leveraged the people to perform blood and urine tests at regular intervals at home. According to WHO, 1 billion people in the world are suffering from hypertension, and 422 million people are suffering from diabetes.

The increasing prevalence of chronic kidney diseases among these people is driving significant growth in the market. The male segment is the leading one in this test in comparison to the female. Due to rising awareness of personal health and hygiene, a large number of people in the world's population go for medical checkups frequently, which include kidney tests as well. The rise in health initiatives both in the public and private sectors is driving growth in the market rapidly.

Another big region in the market is Asia Pacific, which is expected to dominate during the forecast period due to its large population, as the Asia Pacific region has 60% of the world's total population, so the increasing number of older people in countries like China, India, and South Korea is driving growth in the market significantly. Rising disposable income and increasing urbanization are driving growth in the market, along with government initiatives in the region to propel significant growth in the market.

Middle East, Africa, and Latin America are witnessing significant growth in the market due to rapidly growing health sectors in countries like Brazil, Argentina, Chile, and Argentina. In MEA countries like Israel, South Africa, Saudi Arabia, and the United Arab Emirates are contributing to market growth significantly. The presence of key players in the market is another big reason behind the growth in the market.

 Key Players

·         Beacon Diagnostics PVT. Ltd.

·         Eagle Biosciences Inc.

·         Express Biotech International

·         Arkyne Technology S.L.

·         Thermo Fisher Scientific Inc.

·         F.Hoffman La Roche Ltd.

·         Abbott Healthcare Pvt. Ltd.

·         Arbor Assays Inc.

·         PerkinElmer Inc.

·         Other Players